Turner C H, Owan I, Brizendine E J, Zhang W, Wilson M E, Dunipace A J
Biomechanics and Biomaterials Research Center, Indiana University Schools of Medicine and Dentistry, Indianapolis 46202, USA.
Bone. 1996 Dec;19(6):595-601. doi: 10.1016/s8756-3282(96)00278-5.
Renal insufficiency is known to increase plasma fluoride levels, which may increase the risk of fluorosis and osteomalacia. The purpose of this study was to determine the effects of fluoride on skeletal fragility and mineralization in renal-deficient animals. We evaluated the skeleton of rats with surgically induced renal deficiency (4/5 nephrectomy) that were chronically exposed to fluoridated water at concentrations of 0, 5, 15, and 50 ppm for a period of 6 months. The chosen fluoride doses caused plasma fluoride levels equivalent to those in humans consuming fluoridated water levels of 0, 1, 3, and 10 ppm, respectively. Animals with renal deficiency drank about 60% more water and excreted 85% more urine than control animals. Glomerular filtration rate (GFR) was decreased 68% and plasma BUN was increased fourfold in rats with renal deficiency. Plasma fluoride was strongly correlated with 1/GFR and was greatly increased by renal deficiency in all animals consuming fluoridated water. There was a strong positive, nonlinear relationship between plasma fluoride and bone fluoride levels, suggesting nonlinear binding characteristics of fluoride to bone. The amount of unmineralized osteoid in the vertebral bone was related to the plasma fluoride levels. Vertebral osteoid volume was increased over 20-fold in animals with renal deficiency that received 15 or 50 ppm fluoride, suggesting osteomalacia. Should osteomalacia be defined as a tenfold increase in osteoid volume, there appeared to be a threshold plasma fluoride level of about 20 micromol/L, above which osteomalacia was observed consistently. This plasma fluoride level was not achieved in control rats regardless of fluoride intake, nor was it achieved in renal-deficient rats receiving 0 or 5 ppm fluoride. A fluoride concentration of 50 ppm reduced femoral bone strength by 11% in control rats and by 31% in renal-deficient rats. Vertebral strength also was decreased significantly in renal-deficient rats given 50 ppm fluoride. In conclusion, fluoridated water in concentrations equivalent to 3 and 10 ppm in humans, caused osteomalacia and reduced bone strength in rats with surgically-induced renal deficiency.
已知肾功能不全可使血浆氟水平升高,这可能会增加氟中毒和骨软化症的风险。本研究的目的是确定氟对肾缺乏动物骨骼脆性和矿化的影响。我们评估了通过手术诱导肾缺乏(4/5肾切除)的大鼠的骨骼,这些大鼠长期暴露于浓度为0、5、15和50 ppm的氟化水中,为期6个月。所选择的氟剂量导致血浆氟水平分别相当于饮用0、1、3和10 ppm氟化水的人类的血浆氟水平。肾缺乏的动物比对照动物多饮用约60%的水,多排泄85%的尿液。肾缺乏大鼠的肾小球滤过率(GFR)降低了68%,血浆尿素氮增加了四倍。血浆氟与1/GFR密切相关,并且在所有饮用氟化水的动物中,肾缺乏都会使其大幅增加。血浆氟与骨氟水平之间存在强烈的正非线性关系,表明氟与骨的结合具有非线性特征。椎骨中未矿化类骨质的量与血浆氟水平有关。接受15或50 ppm氟的肾缺乏动物的椎骨类骨质体积增加了20多倍,提示骨软化症。如果将骨软化症定义为类骨质体积增加十倍,那么似乎存在一个约20微摩尔/升的血浆氟阈值水平,高于该水平则持续观察到骨软化症。无论氟摄入量如何,对照大鼠均未达到该血浆氟水平,接受0或5 ppm氟的肾缺乏大鼠也未达到该水平。50 ppm的氟浓度使对照大鼠的股骨强度降低了11%,使肾缺乏大鼠的股骨强度降低了31%。给予50 ppm氟的肾缺乏大鼠的椎骨强度也显著降低。总之,相当于人类3和10 ppm浓度的氟化水,在手术诱导肾缺乏的大鼠中导致了骨软化症并降低了骨强度。